Amenis Bioscience, Inc.

City:

Seoul

Country:

South Korea

Published Applications:

Last publication date:

2023-05-04

Patent Grants:

Last grant date:

2026-02-10

Top Inventors for applications by Amenis Bioscience, Inc.

These are the the leading inventors for applications assigned to Amenis Bioscience, Inc.:

Hisanaka Ito 2 Hachioji-shi, Tokyo, Japan
Hisanaka Ito 2 Hachioji, Japan
Takayoshi OKABE 2 Tokyo, Japan
Yusuke Nakatsu 1 Hiroshima-shi, Hiroshima, Japan

Takayoshi Okabe 1 Bunkyo-ku, Tokyo, Japan
Yusuke Nakatsu 1 Higashihiroshima-shi Hiroshima, Japan
Yusuke Nakatsu 1 Higashihiroshima, Japan
Tomoichiro Asano 1 Higashihiroshima-shi Hiroshima, Japan

Tomoichiro Asano 1 Hiroshima, Japan
Tomoichiro Asano 1 Higashihiroshima, Japan
Tomoichiro Asano 1 Hiroshima-shi, Hiroshima, Japan
Takayoshi Okabe 1 Bunkyo-ku, Japan

Yusuke Nakatsu 1 Hiroshima, Japan

Recent patent applications by Amenis Bioscience, Inc.

Amenis Bioscience, Inc. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-05-04 ✅ Patent 12,545,643 granted on 2026-02-10

US20230133581A1

Chemistry; metallurgy

Novel 3,5-Diaminobenzoic Acid Compound, and PIN1 Inhibitor and Therapeutic Agent for Inflammatory Diseases Using Same

#2 | 2020-12-10 ✅ Patent 12,357,626 granted on 2025-07-15

US20200383967A1

Human necessities

Novel Anthranilic Acid-Based Compound, and Pin1 Inhibitor, Therapeutic Agent for Inflammatory Diseases and Therapeutic Agent for Cancer That Use the Same

AssigneeID:

658934 ⎘